Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02654 (long intergenic non-protein coding RNA 2654) is a non-coding RNA gene in humans that gives rise to a transcript longer than 200 nucleotides, with no known protein-coding ability[1][3][5]. As a member of the long intergenic non-coding RNA (lincRNA) family, its biological function remains uncharacterized; no protein products or disease associations have been identified, and there are currently no reports supporting therapeutic targeting or biomarker utility for LINC02654[1][3][5]. LincRNAs broadly participate in diverse regulatory processes such as chromatin remodeling, transcription regulation, and RNA stabilization, but individual functions must be established experimentally and no such information exists for LINC02654 as of now[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2654 (LINC02654).